Today: November 25, 2017, 12:57 am
  
Health

Newly released market study: Algeria Pharmaceuticals & Healthcare Report Q2 2017

Recently published research from Business Monitor International, "Algeria Pharmaceuticals & Healthcare Report Q2 2017", is now available at Fast Market Research
Newly released market study: Algeria Pharmaceuticals & Healthcare Report Q2 2017
PR-Inside.com: 2017-03-20 14:51:36
The Algeria Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Algeria Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Algeria pharmaceutical and healthcare industry.

Key Benefits

Benchmark BMI's pharmaceutical and healthcare market forecasts for Algeria, to test other views - a key input for successful budgeting and strategic business planning in the Algerian pharmaceutical and healthcare market.

Target business opportunities and risks in the Algerian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Algeria.

Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Full Report Details at
- www.fastmr.com/prod/1270559_algeria_pharmaceuticals.aspx?afid=70 ..

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI�s forecast analysis, and taken together with BMI�s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:

Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per �000 population).

Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).

Patented Drug Market: Prescription drug sales (USDbn & % of total sales).

Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).

OTC Drug Market: OTC sales (USDbn & % of total sales).

Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.

BMI�s Pharmaceuticals and Healthcare Risk Reward Index

BMI�s Risk Reward Index provides investors (both national and multinational) looking for opportunities in the region with a clear country-comparative assessment of the market�s risks and potential rewards. Each of the country markets are scored using a sophisticated model that includes more than 40 industry, economic and demographic data points to provide indices of highest to lowest appeal to investors, with each position explained.

Market Summary

A snapshot of key market characteristics, including total size of the pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape

Industry Developments

A focus on government healthcare reforms, epidemiological trends, mergers and acquisitions, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Regulatory Regime

Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as analysis of the overall regulatory burden.

Competitive Landscape

The competitive landscape section provides comparative company analyses and index by USD sales and % share of total sales � for the total pharmaceutical sector, as well as the OTC, generics and distribution sub-sectors.

Company Profiles*

Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of BMI�s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010&afid=701

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Press Information


Published by
Bill Thompson
18008448156
e-mail
www.fastmr.com



# 833 Words
Related Articles
More From The Author
Mexico Commercial Banking Report Q2 2017 - [..]
The Mexico Commercial Banking Report has been researched at source and features BMI Research's independent assessment and forecasts [..]
Just Published: "France Oil & Gas Report [..]
The overall level of investment in exploration and production in France remains weak and this trend is unlikely to alter [..]
Just Published: "Taiwan Infrastructure Report Q1 [..]
The Taiwan Infrastructure Report features BMI Research's market assessment and forecasts covering public procurement and spending [..]
"Chile Information Technology Report Q1 2017" is [..]
The Chile Information Technology Report features BMI Research's market assessment and independent forecasts covering personal computers [..]
Market Report, "Oman Tourism Report Q2 2017", [..]
The Oman Tourism Report has been researched at source and features BMI Research's independent assessment and forecasts for tourist [..]
 
More From Health
Cannabis revolution brings unintended advancements
With the acceleration of technology and it's ever-growing, widespread use, the cannabis industry is not isolate from this societal [..]
World Diabetes Day: Combating diabetic retinopathy in [..]
News release Preventing the preventable: Combating diabetic retinopathy in at risk women November 14, 2017 - report from Los [..]
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% [..]
SINGAPORE, Nov 1, 2017 - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today [..]
Endovision’s Range of Portable LED Examination Lights [..]
Endovision Australia, a leader in providing surgical instruments, has a range of portable LED examination lights that are excellent [..]
SGX-Listed Singapore eDevelopment Subsidiary Global BioLife [..]
SINGAPORE, Oct 24, 2017 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that U.S. [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.